ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma. Nicolau-Neto P, Peryassu BC, de Carvalho FN, Souza-Santos PT, et al. Head Neck 2024;46:785-796.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nicolau-Neto P, Peryassu BC, de Carvalho FN, Souza-Santos PT, et al. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma. Head Neck 2024;46:785-796.
PMID: 38196304